OZEM Holdings
27 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
The fund reports 29 holdings; the file lists 27.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 13.33% | 6,323 | $7.5M |
| 2 | Novo Nordisk A/S | 11.45% | 168,720 | $6.5M |
| 3 | Pfizer Inc | 7.72% | 155,443 | $4.4M |
| 4 | CSPC Pharmaceutical Group Ltd (1093.HK) | 6.50% | 2,930,000 | $3.7M |
| 5 | Viking Therapeutics Inc | 4.89% | 96,697 | $2.8M |
| 6 | Kailera Therapeutics Inc | 4.87% | 260,799 | $2.7M |
| 7 | Hanmi Pharm Co Ltd (128940.KS) | 4.78% | 6,768 | $2.7M |
| 8 | Chugai Pharmaceutical Co Ltd (4519.T) | 4.62% | 67,500 | $2.6M |
| 9 | Ascletis Pharma Inc (1672.HK) | 4.53% | 2,375,000 | $2.6M |
| 10 | Amgen Inc | 4.37% | 5,971 | $2.5M |
| 11 | AstraZeneca PLC | 3.84% | 13,509 | $2.2M |
| 12 | Zealand Pharma A/S (ZEAL.CO) | 3.65% | 55,165 | $2.1M |
| 13 | Roche Holding AG (ROP.SW) | 3.29% | 4,286 | $1.9M |
| 14 | Jiangsu Hengrui Pharmaceuticals Co Ltd (1276.HK) | 2.90% | 261,600 | $1.6M |
| 15 | United Laboratories International Holdings Ltd/The (3933.HK) | 2.83% | 1,644,000 | $1.6M |
| 16 | Hansoh Pharmaceutical Group Co Ltd (3692.HK) | 2.79% | 364,000 | $1.6M |
| 17 | Innovent Biologics Inc (1801.HK) | 2.51% | 114,000 | $1.4M |
| 18 | Structure Therapeutics Inc | 2.15% | 45,508 | $1.2M |
| 19 | Gubra A/S (GUBRA.CO) | 2.09% | 27,392 | $1.2M |
| 20 | MBX Biosciences Inc | 1.99% | 20,530 | $1.1M |
| 21 | Gilead Sciences Inc | 1.85% | 7,109 | $1.0M |
| 22 | Rhythm Pharmaceuticals Inc | 1.39% | 8,890 | $786.3K |
| 23 | Shionogi & Co Ltd (4507.T) | 1.30% | 41,800 | $730.4K |
| 24 | First American Government Obligations Fund 12/01/2031 (FGXXX) | 0.33% | 185,749 | $185.7K |
| 25 | Wave Life Sciences Inc | 0.28% | 44,641 | $158.0K |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 43.13%
- China: 19.47%
- Denmark: 17.04%
- Japan: 6.00%
- South Korea: 4.38%
- United Kingdom: 3.76%
- Switzerland: 3.18%
- Hong Kong: 2.95%
- Other: 0.09%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.